CO5601024A2 - Uso de alquilfosfocolinas para el tratamiento preventivo de enfermedades causadas por protozoos - Google Patents
Uso de alquilfosfocolinas para el tratamiento preventivo de enfermedades causadas por protozoosInfo
- Publication number
- CO5601024A2 CO5601024A2 CO04070642A CO04070642A CO5601024A2 CO 5601024 A2 CO5601024 A2 CO 5601024A2 CO 04070642 A CO04070642 A CO 04070642A CO 04070642 A CO04070642 A CO 04070642A CO 5601024 A2 CO5601024 A2 CO 5601024A2
- Authority
- CO
- Colombia
- Prior art keywords
- preventive treatment
- miltefosine
- active ingredient
- use according
- total daily
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10203195A DE10203195A1 (de) | 2002-01-25 | 2002-01-25 | Verwendung von Alkylphosphocholinen in der Präventivbehandlung von Protozoenerkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5601024A2 true CO5601024A2 (es) | 2006-01-31 |
Family
ID=7713213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO04070642A CO5601024A2 (es) | 2002-01-25 | 2004-07-23 | Uso de alquilfosfocolinas para el tratamiento preventivo de enfermedades causadas por protozoos |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1467742A1 (pt) |
| JP (1) | JP2005515244A (pt) |
| CN (1) | CN1622811A (pt) |
| AR (1) | AR038224A1 (pt) |
| AU (1) | AU2003236787B2 (pt) |
| BR (1) | BR0307021A (pt) |
| CA (1) | CA2470185A1 (pt) |
| CO (1) | CO5601024A2 (pt) |
| DE (1) | DE10203195A1 (pt) |
| IL (2) | IL162492A0 (pt) |
| MX (1) | MXPA04007193A (pt) |
| NZ (1) | NZ548040A (pt) |
| PE (1) | PE20030732A1 (pt) |
| TW (1) | TWI339582B (pt) |
| WO (1) | WO2003061669A1 (pt) |
| ZA (1) | ZA200404690B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT501545B1 (de) * | 2005-02-23 | 2007-10-15 | Obwaller Andreas Dr | Reinigungsmittel für kontaktlinsen |
| EP1800684A1 (en) * | 2005-12-20 | 2007-06-27 | Zentaris GmbH | Novel alkyl phospholipid derivatives and uses thereof |
| UY30042A1 (es) * | 2005-12-19 | 2007-07-31 | Zentaris Gmbh | Nuevos derivados de alquilfosfolípidos con citotoxicidad reducida y usos de los mismos. |
| CN104473941A (zh) * | 2014-12-20 | 2015-04-01 | 长沙佰顺生物科技有限公司 | 一种含有米替福新的药物制剂及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4132344A1 (de) * | 1991-09-27 | 1993-04-01 | Max Planck Gesellschaft | Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis |
| DE4132345A1 (de) * | 1991-09-27 | 1993-04-01 | Max Planck Gesellschaft | Ether-lysolecithine und alkylphosphocholine in liposomen |
| DK0634927T3 (da) * | 1992-03-06 | 2001-10-29 | Lica Pharmaceuticals As | Behandling og profylakse af sygdomme forårsaget af parasitter eller bakterier |
| SI1051159T1 (en) * | 1998-01-22 | 2002-10-31 | Zentaris Ag | Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
| DE10020812C2 (de) * | 2000-04-20 | 2003-06-26 | Robert Koch Inst | Verwendung von Naphthindazol-4,9-chinonen als Antiparasitika |
| WO2002036588A2 (en) * | 2000-11-06 | 2002-05-10 | U.S. Army Medical Research And Materiel Command | Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis |
-
2002
- 2002-01-25 DE DE10203195A patent/DE10203195A1/de not_active Withdrawn
-
2003
- 2003-01-07 IL IL16249203A patent/IL162492A0/xx unknown
- 2003-01-07 BR BR0307021-2A patent/BR0307021A/pt not_active Application Discontinuation
- 2003-01-07 CA CA002470185A patent/CA2470185A1/en not_active Abandoned
- 2003-01-07 JP JP2003561613A patent/JP2005515244A/ja active Pending
- 2003-01-07 NZ NZ548040A patent/NZ548040A/en not_active IP Right Cessation
- 2003-01-07 WO PCT/EP2003/000072 patent/WO2003061669A1/de active IP Right Grant
- 2003-01-07 CN CNA038027062A patent/CN1622811A/zh active Pending
- 2003-01-07 MX MXPA04007193A patent/MXPA04007193A/es active IP Right Grant
- 2003-01-07 EP EP03731619A patent/EP1467742A1/de not_active Ceased
- 2003-01-07 AU AU2003236787A patent/AU2003236787B2/en not_active Expired
- 2003-01-13 TW TW092100614A patent/TWI339582B/zh not_active IP Right Cessation
- 2003-01-20 PE PE2003000061A patent/PE20030732A1/es not_active Application Discontinuation
- 2003-01-24 AR ARP030100214A patent/AR038224A1/es unknown
-
2004
- 2004-06-14 ZA ZA200404690A patent/ZA200404690B/en unknown
- 2004-06-14 IL IL162492A patent/IL162492A/en active IP Right Grant
- 2004-07-23 CO CO04070642A patent/CO5601024A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL162492A (en) | 2009-12-24 |
| TWI339582B (en) | 2011-04-01 |
| EP1467742A1 (de) | 2004-10-20 |
| AU2003236787B2 (en) | 2007-03-22 |
| MXPA04007193A (es) | 2004-10-29 |
| TW200302103A (en) | 2003-08-01 |
| NZ548040A (en) | 2007-06-29 |
| IL162492A0 (en) | 2005-11-20 |
| JP2005515244A (ja) | 2005-05-26 |
| AR038224A1 (es) | 2005-01-05 |
| WO2003061669A1 (de) | 2003-07-31 |
| ZA200404690B (en) | 2004-09-27 |
| CN1622811A (zh) | 2005-06-01 |
| BR0307021A (pt) | 2004-11-03 |
| PE20030732A1 (es) | 2003-09-27 |
| CA2470185A1 (en) | 2003-07-31 |
| DE10203195A1 (de) | 2003-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05002883A (es) | Formas de dosis y terapias relacionadas. | |
| ES2156028T3 (es) | Composiciones que contienen tetrahidrolipstatina | |
| CR8352A (es) | Formulaciones farmaceuticas, procedimientos y pautas de dosificacion para el tratamiento y prevencion de sindromes coronarios agudos | |
| RU94046316A (ru) | Применение высокоэффективных фосфонатов при изготовлении лекарственных средств для лечения остеопороза | |
| ATE418324T1 (de) | Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen | |
| BR9916224A (pt) | Forma de dosagem farmacêutica oral, processos para a manufatura de uma forma de dosagem fixa, para o tratamento e a profilaxia de distúrbios gastrintestinais e para evitar efeitos colaterias gastrintestinais, uso de uma forma de dosagem, combinação, e, embalagem tipo ampola | |
| ECSP078023A (es) | Ingrediente farmacéutico activo en base a canabinoide | |
| AR046773A1 (es) | Formulaciones farmaceuticas de bisfosfonatos | |
| MXPA02012792A (es) | Composicion y forma de de dosificacion para liberacion gastrica retardada de alendronato y/u otros bis-fosfonatos. | |
| AR029542A1 (es) | Composiciones para el cuidado bucal que contienen clorito y sus metodos | |
| BR0104228A (pt) | Derivados do ácido de alquilamino úteis como agentes farmacêuticos, método para fabricação de um composto, composição farmacêutica, métodos para tratamentos diversos e uso de um composto na fabricação de um medicamento para tratamentos diversos | |
| TR200102067T2 (tr) | Topikal formülasyonların mukoza boşluğuna verilmesi için aplikatör | |
| ES2109899T1 (es) | Metodo, composiciones y kits para aumentar la biodisponibilidad oral de agentes farmaceuticos. | |
| MXPA05003366A (es) | Inhibidores de la proteina reguladora de conductancia transmembranal de la fibrosis quistica y usos de los mismos. | |
| RU2007104774A (ru) | Комбинация анти-вич ингибиторов обратной транскриптазы и протеазы | |
| ECSP045029A (es) | Composiciones de valdecoxib de disgregación intraoral | |
| ES2175663T3 (es) | Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis. | |
| AR044200A1 (es) | Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo | |
| ECSP034826A (es) | Método para fabricar una composición farmacéutica de dosis baja | |
| AR030039A1 (es) | Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento | |
| AR033151A1 (es) | Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares | |
| HUP0401672A2 (hu) | Kis koncentrációjú peroxid alkalmazása hüvelyi fertőzések gyógyító vagy megelőző kezelésénél | |
| ES2108014T3 (es) | Composicion antiviral de 3'-azido-2',3'-dideoxi-5-metilcitidina. | |
| CO5601024A2 (es) | Uso de alquilfosfocolinas para el tratamiento preventivo de enfermedades causadas por protozoos | |
| UY26595A1 (es) | Formulaciones de entecavir de dosis bajas y uso |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |